Best Healthcare Companies in Flanders, Belgium
The 129 best Healthcare companies in Flanders, Belgium in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Ablynx.
Ranked: Best Healthcare companies in Flanders
| # | Company | Last round | Disclosed funding | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 3Action Sports Nutrition Provider of dietary and food supplements | — | — | 5 | luc noeyens CEO | Cart FunctionalityShopifyAmazon Web Services+25 | Top 5M | — | — |
| 2 | Across Health Provider of consulting services | — | — | 18 18 → 35 (+94%) | — | Linkedin Sign-inGoogle MapsVimeo+29 | Top 50M | — | — |
| 3 | Adhoc Clinical A clinical research organization | — | — | — | Nancy Cottigny Founder | — | — | — | — |
| 4 | ADO Icarus Chain of senior living centers | — | — | 138 | Alex Verheyden Managing Director | — | — | — | — |
| 5 | Advipro Provider of testing and preclinical consulting services | — | — | 141 | Peter Scheyltjens Founder & CEO | — | — | — | — |
| 6 | Amaron Provider of healthcare IT and consultancy services | — | — | 35 35 → 45 (+29%) | — | WordPressMySQLRedis+29 | Top 10M | — | 1 job opening · 1 launch · 1 partnership |
| 7 | AML Provider of clinical trial supply services | — | — | 4 | — | — | — | — | — |
| 8 | Amophar Company specializing in marketing and distributing healthcare products to pharmacies and para-pharmacies | — | — | — | — | — | — | — | — |
Top 12 Healthcare companies in Flanders
#1
Series B · Ghent, Flanders · founded 2019 · 16 employees$16.3Mraised▾
Xeos is a company that specializes in specimen imaging for surgical procedures. Their flagship product, the XEOS AURA 10, is the first-ever PET-CT Specimen Imager for the operating room. They aim to provide value for patients, surgeons, and imaging professionals.
- Jan 2026Series B$16.3M
#2
Seed · Ghent, Flanders · founded 2022 · 6 employees$5.7Mraised▾
Developer of software enhancing nuclear medicine imaging workflows for improved patient care. The software solutions assist physicians throughout their workflow, from image acquisition to diagnosis and follow-up. The company's flagship product delivers enhanced PET images that aim to boost patient safety and streamline operations for more efficient imaging centers. By reducing radiation, costs, and logistical barriers, the goal is to make nuclear imaging more available, giving patients faster access to the right treatment. More efficient use of radiotracers will also lessen the environmental impact, fostering a more sustainable healthcare system.
- Apr 2025Seed$5.7M
- 2022Seed—
#3
Acquired · Ghent, Flanders · founded 2001 · 419 employees$86.3Mraised▾
Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, hematology, oncology and pulmonary diseases. The Company has approximately 45 proprietary and partnered projects in the pipeline and five nanobodies in clinical development.
#4
Deadpooled · Turnhout, Flanders · founded 2006 · 29 employees$63.7Mraised▾
Provider of educational support and humanitarian aid for children. This organization works to improve the lives of children globally, focusing on providing quality education, particularly in areas affected by poverty, conflict, or emergencies. Their initiatives include supporting school meals, providing educational materials, and creating safe learning environments. They also offer various avenues for individuals and corporations to contribute to their mission. The organization's efforts aim to empower children through education, ensuring their well-being and development.
#5
Funding Raised · Hasselt, Flanders · founded 2015 · 34 employees$2Mraised▾
Provider of medical monitoring, certificate management, reporting, and other services
- Jan 2023Grant (prize money)$482.5K
- Mar 2022Grant (prize money)$334.1K
- Dec 2021Grant (prize money)$149.3K
- Mar 2021Grant (prize money)$303.4K
#6
Seed · Diepenbeek, Flanders · founded 2018 · 5 employees$1.1Mraised▾
SimAbs is a center of excellence for continuous bioprocessing. Their platform enables fast, flexible, and cost-effective biologics manufacturing.
- Oct 2023Seed$1.1M
#7
Series A · Genk, Flanders · founded 2018 · 12 employees$5.4Mraised▾
Provider of operating room process analysis and improvement recommendations. The company offers data collection and digital twin simulation to identify improvement scenarios. It delivers insights, global benchmarking, and actionable plans. The company equips teams with tools for data-driven decisions, aiming to improve operating room efficiency.
- Oct 2021Series A$4.2M
- Sep 2020Seed$1.2M
- 2018Seed—
#8
Series A · Temse, Flanders · founded 2021 · 4 employees$3.7Mraised▾
Developer of a healthcare data platform intended to bridge the gap between data providers and the research industry. The company's platform offers insight into therapeutic outcomes, better site selection for clinical studies, monitoring safety and adverse effects, or optimizing processes in a hospital, enabling healthcare providers and life science industry clients to access structured, validated, and anonymized real-world data to gain insights and provide better care.
- Mar 2022Series A$3.7M
#9
Acquired · Kuringen, Flanders · founded 2000$13.6Mraised▾
Portfolio of surgical products
#10
Seed · Hasselt, Flanders · founded 2019 · 7 employees$1.6Mraised▾
Provider of X-ray equipment inspection services
- Jan 2021Seed$1.6M
- 2019Seed—
#11
Acquired · Tongeren, Flanders · founded 2007 · 9 employees$707.1Kraised▾
SEPS is engaged in developing prodrug approaches and drug delivery systems. The company develops prodrugs, lipophilic prodrugs systems, and self-emulsifying prodrug systems in various therapeutic areas including infectious diseases, oncology, migraine, & chemotherapy-induced and postoperative nausea vomiting. Its pipeline products comprise oral dosage forms of drugs that are currently administered intravenously and long-acting injectables of drugs, which are currently delivered through daily oral administration.The company also provides product development services which include preclinical, pre-formulation, liquid and solid formulation, dosage form, analytical, and bioanalytical development services, as well as scaling-up services
- Jan 2021Grant (prize money)$314.3K
- Jan 2017Grant (prize money)$392.7K
- 2008Seed—
#12
Funding Raised · Antwerp, Flanders · founded 2016 · 5 employees$197.5Kraised▾
Provider of healthcare & management consulting, drone transportation, and other services
- Nov 2022Grant (prize money)$197.5K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.